The new oral anticoagulants: Reasonable alternatives to warfarin

Dabigatran (a direct thrombin inhibitor) and rivaroxaban, apixaban, and edoxaban (direct activated factor X inhibitors) are increasingly being used in clinical practice. Compared with vitamin K antagonists, they are more convenient, do not require laboratory monitoring, have limited drug and food in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cleveland Clinic journal of medicine 2015-12, Vol.82 (12), p.847-854
Hauptverfasser:	Roca, Bernardino, Roca, Manuel
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants - therapeutic use Antithrombins - therapeutic use Atrial Fibrillation - complications Atrial Fibrillation - drug therapy Dabigatran - therapeutic use Factor Xa Inhibitors - therapeutic use Hemorrhage - chemically induced Humans Pulmonary Embolism - drug therapy Pyrazoles - therapeutic use Pyridines - therapeutic use Pyridones - therapeutic use Rivaroxaban - therapeutic use Stroke - etiology Stroke - prevention & control Thiazoles - therapeutic use Venous Thrombosis - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!